Texas A&M researcher explains how embryo fights retroviral infectionJune 25, 2010
Some viruses insert themselves into the host's DNA during infection in a process called retroviral integration, causing several diseases, including AIDS and cancer, notes a Texas A&M researcher who specializes in fetal diseases. However, stem cells that give rise to the early embryo and yolk sac fight back, inhibiting further infection by aggressively silencing the invading viral DNA, says Michael Golding of the Department of Veterinary Physiology and Pharmacology.
The work of the researcher was recently published in Cell Stem Cell.
Early mammalian embryos actually possess three stem cell lineages: ES (embryonic stem), TS (trophectoderm stem), and XEN (extraembryonic endoderm), which give rise to the fetus, placenta and yolk sac respectively, the Texas A&M researcher explains. Using the mouse as a model organism, Golding and his colleagues demonstrate that the mechanisms silencing gene expression are different between each of the three stem cell types.
"Much like a closed book cannot be read while an open book can, the DNA encoding genes can either be tightly wound up and silent or in a relaxed, open, active state," Golding explains. "The mechanisms that control this gene packaging are called epigenetic as they represent a level of regulation that is above or 'epi' to genetics."
The study shows "retroviral silencing in XEN cells is epigenetic in origin" and that "the three cell lineages of early mammalian embryo have vastly different viral silencing strategies as well as different capacities to suppress retroviral activity."
To examine the validity of a common assumption that these stem cells use similar mechanisms to silence retroviruses, Golding infected the mouse embryo stem cells with mouse leukemia virus (MLV) and monitored the virus' activity.
ES cells showed a progressive decline in virus activity, while TS cells had a constant level of virus activity. XEN cells, however, exhibited extremely aggressive and rapid silencing of virus activity, according to the study.
"Epigenetics is an exciting new field of research which is altering the way we think about fetal nutrition and exposure to environmental chemicals," Golding adds. "This discovery that all three stem cell types of the early embryo utilize slightly different mechanisms to control gene expression has profound implications for how we diagnose and treat fetal diseases."
Texas A&M University
Related Retroviral Current Events and Retroviral News Articles
Retroviral RNA may play a part in liver cancer
An international group led by RIKEN in Japan and INSERM in France have found that retroviral long-terminal-repeat (LTR) promoters--a type of repetitive element that are widely distributed in the human genome--are highly activated in hepatocellular carcinomas, the most common type of liver cancer.
Dormant viral genes may awaken to cause ALS
Scientists at the National Institutes of Health discovered that reactivation of ancient viral genes embedded in the human genome may cause the destruction of neurons in some forms of amyotrophic lateral sclerosis (ALS).
HIV patients should be included in early clinical trials of anti-TB drugs
Tuberculosis is the number one cause of death in HIV-infected patients in Africa and a leading cause of death in this population worldwide, yet the majority of these patients are excluded from the early stages in the development of new, anti-tuberculosis drugs.
First-ever observation of the native capside of a retrovirus
Bovine leukemia virus (BLV) is an infectious disease that affects the immune system of cattle, causing immunodeficiency and in some cases triggering the development of leukemia or solid tumors in the form of lymphomas.
Study shows role of disease-fighting cells in HIV-related neurological damage
Despite symptom-stifling anti-retroviral drugs, as many as half of all patients living with HIV experience neurological damage tied to chronic inflammation in the brain fueled by the body's own immune defenses.
Researchers 'un-can' the HIV virus
If the human immunodeficiency virus (HIV) is a bit like a hermetically sealed tin can no one has yet been able to break open, the good news is that researchers at the CHUM Research Centre, affiliated with the University of Montreal, have identified a way to use a "can opener" to force the virus to open up and to expose its vulnerable parts, allowing the immune system cells to then kill the infected cells.
Viruses: You've heard the bad -- here's the good
In sharp contrast to the gastrointestinal distress it causes in humans, the murine (mouse infecting) norovirus plays a role in development of the mouse intestine and its immune system, and can actually replace the beneficial effects of certain gut bacteria when these have been decimated by antibiotics.
International experts call for an end to preventable deaths from acute kidney injury by 2025
Preventable deaths caused by acute kidney injury (AKI) could be nearly eliminated in just 10 years, according to leading medical experts.
New protein booster may lead to better DNA vaccines and gene therapy
Scientists have discovered a new way to manipulate how cells function, a finding that might help advance an experimental approach to improving public health: DNA vaccines, which could be more efficient, less expensive and easier to store than traditional vaccines.
Fewer viral relics may be due to a less bloody evolutionary history
A researcher from Plymouth University School of Biomedical and Healthcare Sciences had led an international team investigating viruses that entered the DNA of our ancestors millions of years ago.
More Retroviral Current Events and Retroviral News Articles